Genomics

Dataset Information

0

CRISPR/Cas9 mediated deletion of the adenosine A2AR enhances CAR T cell efficacy

ABSTRACT: CRISPR/Cas9 mediated deletion of the adenosine A2AR enhances CAR T cell efficacy

PROVIDER: PRJNA657017 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR12447307.fastq.gz Fastqsanger.gz
SRR12447308.fastq.gz Fastqsanger.gz
SRR12447309.fastq.gz Fastqsanger.gz
SRR12447310.fastq.gz Fastqsanger.gz
SRR12447311.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 60

Similar Datasets

Genomics CRISPR/Cas9 mediated deletion of the adenosine A2AR enhances CAR T cell efficacy [murine_CRISPR_A2AKO_RNA-seq]
| PRJNA657024 | ENA
Genomics CRISPR/Cas9 mediated deletion of the adenosine A2AR enhances CAR T cell efficacy [human_CRISPR_A2AKO_RNA-seq]
| PRJNA657021 | ENA
Genomics CRISPR/Cas9 mediated deletion of the adenosine A2AR enhances CAR T cell efficacy [NECA_RNA-seq]
| PRJNA657022 | ENA
Genomics Tumor-site directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors. [human ATACseq]
2025-03-16 | GSE284616 | GEO
Transcriptomics Tumor-site directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors. [Mouse RNAseq constitutive]
2025-03-16 | GSE284614 | GEO
Transcriptomics Tumor-site directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors. [Human RNAseq inducible]
2025-03-16 | GSE284618 | GEO
Transcriptomics Tumor-site directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors. [human RNAseq constitutive]
2025-03-16 | GSE284615 | GEO
Transcriptomics Tumor-site directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors. [CD8 inducible human RNAseq]
2025-03-16 | GSE284619 | GEO
Transcriptomics CRISPR/Cas9 mediated deletion of the adenosine A2AR enhances CAR T cell efficacy [NECA_RNA-seq]
2021-03-29 | GSE156189 | GEO
Transcriptomics CRISPR/Cas9 mediated deletion of the adenosine A2AR enhances CAR T cell efficacy [murine_CRISPR_A2AKO_RNA-seq]
2021-03-29 | GSE156191 | GEO